Abstract
Background
Radiotherapy can often lead to thyroid dysfunction. Some studies demonstrated that treatment of breast cancer by RT can expose thyroid gland to high doses of radiation. The aim of this systematic review is to evaluate consideration of thyroid gland as an organ at risk.
Methods
In this systematic review and meta-analysis to select initial studies, a comprehensive search by two independent reviewers was performed. Electronical databases following: Web of Science, Google Scholar, Scopus, PubMed, Elsevier, Embase, ProQuest and Persian databases such as Iranmedex, Magiran, and SID were searched. All searches were restricted to English language between 1985 and 2017. A random effect meta-analysis is applied to estimate pooled effect size across initial studies. Funnel plot with Egger’s test is used to assess potential publication bias.
Results
Totally, five studies (478 samples) were included in meta-analysis. The meta-analyses of result showed that thyroid gland is affected by radiotherapy significantly and the TSH increased after radiotherapy (z = 2.68, P = 0.007). The pooled estimate of difference mean for TSH was 0.90 (95% CI 0.24, 1.55). In studies among patients with breast cancer RT, hypothyroidism was reported more than other thyroid disorders. There was not showed possibility publication bias among studies (P > 0.05).
Conclusion
This study demonstrated that thyroid gland is affected by radiotherapy significantly and the TSH increased after radiotherapy. Protecting thyroid gland during radiation and follow-up of patients with breast cancer RT are suggested for the assessment of thyroid gland dysfunction.
Similar content being viewed by others
References
Kuijpens JL, Nyklíctek I, Louwman MW, Weetman TA, Pop VJ, Coebergh JW. Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid. 2005;15(11):1253–9.
Ferlay J, Héry C, Autier P, Sankaranarayanan R. Global Burden of Breast Cancer. Breast Cancer Epidemiol. 2009. https://doi.org/10.1007/978-1-4419-0685-4_1.
Dorri Giv M, Bahreini Toosi MH, Aghamiri SMR, Akbari F, Taeb S. Calculation of thyroid dose with planner system and evaluation of thyroid function after radiotherapy for patients with breast cancer. J Biomed Phys Eng. 2016;6(4):229–34.
Cardoso LJSF, Martine J, Piccart–William C, Wood–Chie-Mien H. Breast cancer and molecular medicine. Switzerland: Springer; 2006.
Weinberg RA, Hahn WC, Watnick R, Stewart S, Mani SA, Yang J. Rules governing the creation of human tumor cells. Int J Cancer. 2002;100(S13):1.
Early Breast Cancer Trialists’ Collaborative Group. (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–106.
Seyed Yousuf Ali, Gurcharan Singh. Radiation induced Alopecia. Int J Trichol. 2010; 2(2):118–119
Bucci M, Bevan A, Roach M. Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin. 2005;55(2):117–34.
Tunio MA, Al Asiri M, Bayoumi Y, Stanciu LG, Al Johani N, Al Saeed EF. Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study. J Cancer Res Ther. 2015;11(4):684–9.
Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys. 1995;31(5):1165–70.
Bassiri RM, Utiger RD. Thyrotropin-releasing hormone in the hypothalamus of the rat. Endocrinology. 1974;94(1):188–97.
Beck-Peccoz Paolo, Amr Sania. M. Margarida Menezes-Ferreira, Giovanni Faglia, and Bruce D. Weintraub. Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone. N Engl J Med. 1985;312:1085–90.
Jereczek-Fossa B, Alterio D, Jassem J, Tradati N, Orecchia R. Radiotherapy-induced thyroid disorders. Cancer Treat Rev. 2004;30(4):369–84.
Roozbeh N, Azizi M, Darvish L. Pregnancy outcome of abnormal nuchal translucency: a systematic review. J of Clin and Diag Res. 2017;11(3):12–6.
Vandenbroucke JP, Von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297.
Roozbeh N, Nahidi F, Hajiyan S. Barriers related to prenatal care utilization among women. Saudi Med J. 2016;37(12):13–1319.
Joensuu H, Viikari J. Thyroid function after postoperative radiation therapy in patients with breast cancer. Acta Radiol Oncol. 1986;25(3):167–70.
Bruning P, Bonfrèr J, De Jong-Bakker M, Nooyen W, Burgers M. Primary hypothyroidism in breast cancer patients with irradiated supraclavicular lymph node. Br J Cancer. 1985;51(5):659–63.
Reinertsen KV, Cvancarova M, Wist E, Bjøro T, Dahl AA, Danielsen T et al. Thyroid Function in Women after Multimodal Treatment for Breast Cancer Stage II/III: Comparison With Controls From a Population Sample. Int J Radiat Oncol Biol Phys. 2009: 75(3):764–70.
Akureki S, Ibrahim Babalioglu I, Kose K, Saban C. GOKCE. Thyroid dysfunction following supraclavicular irradiation in the management of carcinoma of the breast. Int J of Hema Oncol 2014; 24(2):139–144.
Johansen S, Reinertsen KV, Knutstad K, Olsen DR, Fosså SD. Dose distribution in the thyroid gland following radiation therapy of breast cancer—a retrospective study. Radiat Oncol. 2011;6:68.
Smith GL, Smith BD, Giordano SH, Shih YC, Woodward WA, Strom EA, et al. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer. 2008;112(6):1371–9.
Wolny-Rokicka E, Tukiendorf A, Wydmański J, Roszkowska D, Staniul BS, Zembroń-Łacny A. Thyroid function after postoperative radiation therapy in patients with breast cancer. Asian Pac J Cancer Prev. 2016;17(10):4577–81.
Kim SS, Kim SJ, Bae YT, Lee JY, Kim BH, Kim YK, et al. Factors associated with the development of new onset diffuse thyroid F18-Fluorodeoxyglucose uptake after treatment of breast cancer in patients without a history of thyroid disease or thyroid dysfunction. Thyroid Radiol Nucl Med. 2012;22(1):53–8.
Srikantia N, Rishi K, Janaki MG, Bilimagga R, Ponni A, Rajeev AG, et al. How common is hypothyroidism after external radiotherapy to neck in head and neck cancer patients. J Cancer Res Ther. 2011;32(3):143–8.
Tell R, Lundell G, Nilsson B, Sjödin H, Lewin F. Rolf Lewensohn. Int J of Radiol Oncol Bio Phys. 2004;60(2):395–400.
Garcia-Serra A, Amdur RJ, Morris CG, Ernest M, William M. William Thyroid Function Should Be Monitored Following Radiotherapy to the Low Neck. Am J Clin Oncol. 2011;28(3):255–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval (research involving human participants and/or animals)
This work has not any human or animal participants.
Informed consent
There is no consent for this work.
Rights and permissions
About this article
Cite this article
Darvish, L., Ghorbani, M., Teshnizi, S.H. et al. Evaluation of thyroid gland as an organ at risk after breast cancer radiotherapy: a systematic review and meta-analysis. Clin Transl Oncol 20, 1430–1438 (2018). https://doi.org/10.1007/s12094-018-1875-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-018-1875-7